Atricure Inc. buy Needham & Company LLC
Start price
29.11.23
/
50%
€34.60
Target price
29.11.24
€44.64
Performance (%)
-
End price
30.11.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atricure Inc. | -0.575% | -0.575% | -44.194% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by Needham___Company_LL for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $49.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat
In the thread Trading Atricure Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten